When building a project to operate on battery power for long periods of time, having a microcontroller with a reliable and ...
The PCSK9 inhibitor evolocumab reduced the risk of a first major cardiovascular event in patients with diabetes without known significant atherosclerosis, according to a prespecified subgroup analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results